Trump administration proposes changes to federal marijuana scheduling rules

The Trump administration has announced a move to reschedule marijuana, reclassifying state-licensed medical marijuana as a less-dangerous drug. The decision is seen as a significant shift in the country’s approach to cannabis.

According to reports, the Department of Justice has taken this step, which could potentially expand research and access to medical marijuana for patients. The exact details of the reclassification are not yet clear, but it appears that the administration is seeking to reduce the stigma associated with marijuana use.

The move comes as part of a broader effort to review and revise federal policies on cannabis. While the specifics of the decision have not been released, officials say that it aims to promote greater understanding and research into the potential benefits and risks of marijuana.

As a result of this reclassification, state-licensed medical marijuana will be treated as a less-dangerous drug, which could lead to increased access for patients and researchers. The impact of this move is still being assessed, but it is clear that it represents an important shift in the country’s approach to cannabis.

The decision has been met with varying reactions from different stakeholders, including medical professionals, advocacy groups, and lawmakers. While some have welcomed the move as a step towards greater understanding and access, others have expressed concerns about the potential consequences of this reclassification.

Source: Google News World